Recent advances in understanding the effects of T lymphocytes on mucosal barrier function in allergic rhinitis

被引:3
作者
Yang, Maolin [1 ]
Sun, Liwei [1 ,2 ]
Zhu, Dongdong [1 ,2 ]
Meng, Cuida [1 ,2 ]
Sha, Jichao [1 ,2 ]
机构
[1] Jilin Univ, China Japan Union Hosp, Dept Otolaryngol Head & Neck Surg, Changchun, Peoples R China
[2] Jilin Prov Key Lab Precise Diag & Treatment Upper, Changchun, Peoples R China
基金
中国国家自然科学基金;
关键词
allergic rhinitis; nasal mucosal barrier; T cells; biological therapy; cytokine; BLOOD MONONUCLEAR-CELLS; NASAL-MUCOSA; MOUSE MODEL; STEM-CELLS; INVOLVEMENT; EXPRESSION; HISTAMINE;
D O I
10.3389/fimmu.2023.1224129
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Allergic rhinitis is a non-infectious chronic inflammatory disease of the nasal mucosa that affects T cells and their cytokines. T cells play significant roles in the development of allergic inflammatory diseases by orchestrating mechanisms underlying innate and adaptive immunity. Although many studies on allergic rhinitis have focused on helper T cells, molecular makeup, and pathogenesis-related transduction pathways, pathological mechanisms have not yet been completely explored. Recent studies have suggested that T cell status may play an important role in the interaction between T cells and the nasal mucosal barrier in allergic rhinitis. This study aimed to explore the interactions between T cells and nasal mucosal barriers in allergic rhinitis and to review the therapeutic modalities of pertinent biological agents involving T cells.
引用
收藏
页数:8
相关论文
共 60 条
[1]   Cromolyn-crosslinked chitosan nanoparticles for the treatment of allergic rhinitis [J].
Abruzzo, Angela ;
Cerchiara, Teresa ;
Bigucci, Federica ;
Zuccheri, Giampaolo ;
Cavallari, Cristina ;
Saladini, Bruno ;
Luppi, Barbara .
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2019, 131 :136-145
[2]   Th9 Cells in Allergic Disease [J].
Angkasekwinai, Pornpimon .
CURRENT ALLERGY AND ASTHMA REPORTS, 2019, 19 (05)
[3]   The effect of treatment with fexofenadine and fluticasone propionate on the gene expression levels of Th9 transcription factors in patients with allergic rhinitis [J].
Askari, Ali Asghar ;
Feizollahi, Parisa ;
Rezaiemanesh, Alireza ;
Salari, Farhad ;
Karaji, Ali Gorgin .
HELIYON, 2021, 7 (12)
[4]   Allergies - A T cells perspective in the era beyond the TH1/TH2 paradigm [J].
Berker, Moritz ;
Frank, Larissa Johanna ;
Gessner, Anja Lidwina ;
Grassl, Niklas ;
Holtermann, Anne Verena ;
Hoeppner, Stefanie ;
Kraef, Christian ;
Leclaire, Martin Dominik ;
Maier, Pia ;
Messerer, David Alexander Christian ;
Moehrmann, Lino ;
Nieke, Jan Philipp ;
Schoch, Diana ;
Soli, Dominik ;
Woopen, Christina Marianne Paulina .
CLINICAL IMMUNOLOGY, 2017, 174 :73-83
[5]   Allergic Rhinitis Mechanisms and Treatment [J].
Bernstein, David I. ;
Schwartz, Gene ;
Bernstein, Jonathan A. .
IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA, 2016, 36 (02) :261-+
[6]   Allergic rhinitis: Pathophysiology [J].
Broide, David H. .
ALLERGY AND ASTHMA PROCEEDINGS, 2010, 31 (05) :370-374
[7]   Efficacy of dupilumab on clinical outcomes in patients with asthma and perennial allergic rhinitis [J].
Busse, William W. ;
Maspero, Jorge F. ;
Lu, Yufang ;
Corren, Jonathan ;
Hanania, Nicola A. ;
Chipps, Bradley E. ;
Katelaris, Constance H. ;
FitzGerald, J. Mark ;
Quirce, Santiago ;
Ford, Linda B. ;
Rice, Megan S. ;
Kamat, Siddhesh ;
Khan, Asif H. ;
Jagerschmidt, Alexandre ;
Harel, Sivan ;
Rowe, Paul ;
Pirozzi, Gianluca ;
Amin, Nikhil ;
Ruddy, Marcella ;
Graham, Neil M. H. ;
Teper, Ariel .
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2020, 125 (05) :565-+
[8]   Short-term subcutaneous grass pollen immunotherapy under the umbrella of anti-IL-4: A randomized controlled trial [J].
Chaker, Adam M. ;
Shamji, Mohamed H. ;
Dumitru, Florentina A. ;
Calderon, Moises A. ;
Scadding, Guy W. ;
Makatsori, Melina ;
Jones, Ieuan ;
He, Qiuling A. ;
Subramanian, Kulandayan K. ;
Arm, Jonathan P. ;
Durham, Stephen R. ;
Schmidt-Weber, Carsten B. .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2016, 137 (02) :452-+
[9]  
Chanta A, 2022, ASIAN PAC J ALLERGY, V40, P126, DOI [10.12932/AP-260419-0547, 10.12932/ap-260419-0547]
[10]   Desloratadine citrate disodium injection, a potent histamine H1 receptor antagonist, inhibits chemokine production in ovalbumin-induced allergic rhinitis guinea pig model and histamine-induced human nasal epithelial cells via inhibiting the ERK1/2 and NF-kappa B signal cascades [J].
Chen, Meiling ;
Xu, Shuhong ;
Zhou, Peipei ;
He, Guangwei ;
Jie, Qiong ;
Wu, Yulin .
EUROPEAN JOURNAL OF PHARMACOLOGY, 2015, 767 :98-107